Ro, a direct-to-patient healthcare company, is dedicated to helping patients achieve their health goals by delivering convenient and effective care. The company has revolutionized the healthcare industry by providing high-quality, affordable healthcare without the need for insurance. Ro's vertically integrated platform seamlessly connects telehealth, in-home care, diagnostics, labs, and pharmacy services nationwide, offering a personalized, end-to-end healthcare experience. Since its establishment in 2017, Ro has facilitated over eight million digital healthcare visits in nearly every county in the United States, including 98% of primary care deserts. Additionally, Ro extends its patient-centric solutions, including Workpath, its in-home care API, and Kit, its at-home diagnostic testing service, to other healthcare companies. The company recently secured a significant $150.00M Venture Round investment on 15 February 2022, with participation from leading investors such as FirstMark, BoxGroup, Initialized Capital, General Catalyst, Altimeter, SevenSevenSix, Baupost Group, TQ Ventures, Vine Ventures, and TCG. Ro's innovative approach and substantial support from prominent investors position it as a key player in disrupting the healthcare industry.
